Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Breast Cancer
To Engage and Activate Patients, CRM Alone Isn’t Enough
We talk about patient engagement a lot in healthcare today. But the reality is, we often don’t just want a patient to engage with a piece of content or information; we want them to take action. The traditional CRM and marketing automation are great tools for the former – keeping patients and their healthcare providers connected. But it does little to move beyond a digital connection.
Today’s patients (or, consumers) expect more from all of their relationships, especially their healthcare
Read More
Black Female Co-founders CancerIQ Raises $14M to Improve Cancer Early Detection and Prevention
What You Should Know:
- CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad patient populations, announced today it closed a $14M Series B financing round.
- The Series B round was co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures with participation from McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), and HealthX Ventures.
Inequality in
Read More
XRHealth Secures $10M to Expand Virtual Reality Treatment in the Metaverse
What You Should Know:
- XRHealth, the gateway to the healthcare metaverse, announced today that they raised $10M in funding to expand virtual healthcare treatment in the Metaverse. The funding was backed by HTC, Bridges Israel impact investment fund, AARP, and crowdfunding on StartEngine.com and existing investors.
- XRHealth’s platform is FDA and CE registered and provides an immersive experience for users, transporting them to a virtual world for comprehensive
Read More
Syapse, Pfizer Extends Collaboration to Generate Real-World Evidence in Breast Cancer
What You Should Know:
- Syapse, a real-world evidence company that informs cancer care, announced that it will extend its collaboration with Pfizer to generate real-world evidence in breast cancer.
- This is the third phase of the collaboration, which was first announced in 2019 and renewed in 2021.
Generate Real-World Evidence in Breast Cancer
As part of the next phase of the collaboration, Syapse will provide insights and services to Pfizer, using the Syapse Learning Health Network
Read More
Personalized Screening is Key to Breast Imaging AI Market Reaching $205M by 2025
As October draws to a close, so does Breast Cancer Awareness Month (BCAM), or National Breast Cancer Awareness Month (NBCAM) as it is known in the US. Breast imaging AI vendors are heavily promoting this initiative to raise awareness of the disease and highlight the importance of women attending breast cancer screening appointments. Breast cancer screening programs are an important public health intervention, and initiatives like the BCAM may prompt eligible women to attend their screening
Read More
Biospecimen Procurement for R&D Needs to Look More Like an Online Marketplace
As healthcare digitizes everything from insurance claims to clinical decisions, some functions remain frustratingly analog, old school, and inefficient.
One such function is the distribution of human biospecimens necessary for medical research. Specimens are essential in providing much of the data that researchers examine, EHRs capture, and scientific databases aggregate. Unfortunately, the distribution of specimens and their data to researchers is woefully outdated and inefficient. Frankly,
Read More
A Patient Engagement Strategy Needs to Deliver a Holistic Experience
Researchers from Johns Hopkins published a study in October on the impact of the pandemic on health care delivery. Among its findings, the data show a 21.4% decrease in primary care visits in Q2 of 2020, compared against the average volume of Q2 visits for the previous two years. By contrast, there was a sharp increase in telehealth engagements, accounting for 35.3% of all provider visits in Q2 this year, compared with 4.1% in Q1 and 1.1% in 2018-2019.
Despite the shifts in healthcare
Read More
Volpara Acquires Breast Cancer Risk Assessment Platform CRA Health for $18M
What You Should Know:
- Volpara Health, an integrated breast care platform assisting in the delivery of personalized patient care has acquired breast cancer risk assessment platform CRA Health.
- CRA Health, LLC, is a breast cancer risk assessment company spinoff from Massachusetts General Hospital — a Harvard Medical School teaching hospital. Today the company delivers more than two million assessments annually to women’s imaging clinics.
- CRA software is cloud-based
Read More
Fujifilm & Volpara Partner to Help Clinicians Determine Patient Breast Density
What You Should Know:
- FUJIFILM Medical Systems U.S.A., Inc. and Volpara
Solutions announced the extension of their partnership to provide mammography
facilities and clinicians with breast imaging solutions designed to improve
image quality, streamline workflow and accurately assess a patient's breast
density.
- Building on a successful 6-year partnership, Fujifilm's
customers using ASPIRE Cristalle with Digital Breast Tomosynthesis (DBT) now
have access to the latest innovations from
Read More
